# OGN: Organon & Co.

- Industry: Pharmaceutical Preparations
- Current price: $13.68
- Price updated: Sep 19, 2026
- Total congressional trades: 2
- Politicians trading: 2
- Last traded: Aug 5, 2026
- Source: https://tryglasshouse.ai/companies/OGN.md

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

# Congressional trading history

- Page: 1 of 1
- Results: 2 of 2
- Pagination query parameter: `page`

## 1. Kevin Hern

- Member: Republican, House
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Aug 5, 2026, disclosed Aug 10, 2026
- Market context: $13.57 at trade, $13.68 current (+0.81%)
- Politician: https://tryglasshouse.ai/politicians/H001082.md
- Record: https://tryglasshouse.ai/trades/9df32704-2eb7-487f-80db-9dc3bed1ad2b.md

## 2. Gary C. Peters

- Member: Democrat, Senate
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Jul 10, 2025, disclosed Nov 24, 2025
- Market context: $10.02 at trade, $13.68 current (+36.53%)
- Politician: https://tryglasshouse.ai/politicians/P000595.md
- Record: https://tryglasshouse.ai/trades/7d6ef205-965c-49d2-9bce-0ea806e34d74.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.